Hidrex GmbH

Hidrex GmbH specializes in iontophoresis systems, which are designed to treat hyperhidrosis—a condition causing excessive sweating. These devices use controlled electrical currents to temporarily reduce sweat gland activity in areas like hands and feet. The portfolio includes standalone units and systems tailored for clinical or home use, all focused on non-invasive hyperhidrosis management.

Hidrex GmbH is based in the United States, which means its devices must comply with FDA regulations. The company’s products are classified as Class II medical devices, indicating moderate risk and requiring compliance with specific controls. Since these devices are authorised through the FDA’s 510(k) pathway and carry a Unique Device Identifier (UDI), they are listed in the FDA’s regulatory databases, ensuring transparency and adherence to US medical device standards.

Hidrex GmbH’s devices are listed in the FDA’s regulatory databases, specifically through the 510(k) premarket notification process and the Unique Device Identifier (UDI) system. These registries confirm that the devices meet FDA requirements for Class II medical devices, ensuring they are authorised for use in the US market under applicable regulations.

Hidrex GmbH’s iontophoresis systems are classified as Class II medical devices by the FDA. This classification is based on the moderate risk associated with these devices, which require special controls beyond general controls to ensure safety and effectiveness. The classification influences the regulatory pathway, such as the 510(k) process, which demonstrates that the devices meet FDA standards for their intended use in treating hyperhidrosis.